The European pharmaceutical water market size was estimated at USD 14.24 billion in 2025 and is projected to be worth around USD 31.03 billion by 2035, growing at a CAGR of 8.1% from 2026 to 2035. The European Market is influenced by strict regulatory standards (EMA, GMP) that demand high-purity water, a fast increase in biologics and vaccine production, and more investments in research and development.

Europe Pharmaceutical Water Market Statical Scope

The market is vital for creating high-quality medicines, shaped by the strict rules of the European Medicines Agency (EMA), the growth of biologics and biosimilars , and the demand for sustainable and advanced water treatment technologies. It plays a key role in operations, safety, and regulatory compliance in a rapidly expanding market. The rising production of monoclonal antibodies , vaccines , and cell and gene therapies, which need specially purified water, drives the demand. The industry is quickly embracing automation, IoT, and AI-based purification systems to boost efficiency. There is a strong emphasis on reducing pharmaceutical waste in water systems and enhancing water efficiency, driven by environmental sustainability goals. Europe, particularly in major centers like Germany, France, and the UK, is a rapidly growing area for advanced water treatment solutions and sustainable infrastructure.

Europe Pharmaceutical Water Market, By Type, 2025 (%)

• Water for Injection - The Water for Injection (WFI) segment, with a share of 64%, is vital to the European pharmaceutical water market as it represents the highest-purity water grade needed for producing sterile, injectable drugs and biopharmaceutical (vaccines, mAbs), holding the largest market share.
• HPLC Grade Water - HPLC Grade Water, with a share of 36%, is essential in the European pharmaceutical market because it guarantees precision in High-Performance Liquid Chromatography (HPLC) testing, which is important for drug regulatory compliance, quality control, and R&D.

Europe Pharmaceutical Water Market, By Application, 2025 (%)

• Pharmaceutical & Biotechnology Companies - The Pharmaceutical & Biotechnology Companies segment, with a share of 72%, is essential to the Market as it creates demand through the high-volume, necessary use of purified water for drug development, validation, and manufacturing.
• Academics & Research Laboratories - The Academics & Research Laboratories segment, with a share of 28%, plays a vital role in the European Market as it fosters innovation, aids in preclinical development, and upholds high-purity standards for advanced research in biopharmaceuticals, personalized medicine , and vaccines.

Top Companies in the Europe Pharmaceutical Water Market

• Merck KGaA
• B. Braun Melsungen AG
• Thermo Fisher Scientific, Inc.
• Cytiva (Danaher)
• Fresenius Kabi AG
• Pfizer, Inc.
• CovaChem, LLC
• Intermountain Life Sciences

Segments Covered in the Report

By Type

• HPLC Grade Water
• Water for Injection

By Application

• Pharmaceutical & Biotechnology Companies
• Academics & Research Laboratories